Global HER2 Target Drugs Market Growth 2026-2032
The global HER2 Target Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
United States market for HER2 Target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for HER2 Target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for HER2 Target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key HER2 Target Drugs players cover Roche, GSK, Boehringer Digelheim, Pfizer, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “HER2 Target Drugs Industry Forecast” looks at past sales and reviews total world HER2 Target Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected HER2 Target Drugs sales for 2026 through 2032. With HER2 Target Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 Target Drugs industry.
This Insight Report provides a comprehensive analysis of the global HER2 Target Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER2 Target Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HER2 Target Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 Target Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 Target Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Target Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Activation of the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases can regulate signaling pathways for cell proliferation and survival. HER2 is a non-ligand-binding member of this family and exerts its activity through heterodimerization with other EGFR family members. Activation of HER2 function can promote tumorigenesis, so scientists have begun research on HER2-targeted drugs in HER2 gene-related cancers.
United States market for HER2 Target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for HER2 Target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for HER2 Target Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key HER2 Target Drugs players cover Roche, GSK, Boehringer Digelheim, Pfizer, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “HER2 Target Drugs Industry Forecast” looks at past sales and reviews total world HER2 Target Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected HER2 Target Drugs sales for 2026 through 2032. With HER2 Target Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 Target Drugs industry.
This Insight Report provides a comprehensive analysis of the global HER2 Target Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER2 Target Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HER2 Target Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 Target Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 Target Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Target Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monoclonal Antibodies
- Small Molecule Chemicals
- Antibody Drug Conjugate
- Breast Cancer
- Colorectal Cancer
- Stomach Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- GSK
- Boehringer Digelheim
- Pfizer
- AstraZeneca
- Seagen
- MacroGenics
- Takeda
- Daiichi Sankyo
- Novartis AG
- RemeGen
- Sunshine Guojian
- Hengrui Medicine
- What is the 10-year outlook for the global HER2 Target Drugs market?
- What factors are driving HER2 Target Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do HER2 Target Drugs market opportunities vary by end market size?
- How does HER2 Target Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HER2 Target Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for HER2 Target Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for HER2 Target Drugs by Country/Region, 2021, 2025 & 2032
2.2 HER2 Target Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecule Chemicals
2.2.3 Antibody Drug Conjugate
2.2.4 HER2 Target Drugs Sales by Type
2.2.4.1 Global HER2 Target Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global HER2 Target Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global HER2 Target Drugs Sale Price by Type (2021-2026)
2.3 HER2 Target Drugs Segment by Application
2.3.1 Breast Cancer
2.3.2 Colorectal Cancer
2.3.3 Stomach Cancer
2.3.4 Other
2.3.5 HER2 Target Drugs Sales by Application
2.3.5.1 Global HER2 Target Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global HER2 Target Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global HER2 Target Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global HER2 Target Drugs Breakdown Data by Company
3.1.1 Global HER2 Target Drugs Annual Sales by Company (2021-2026)
3.1.2 Global HER2 Target Drugs Sales Market Share by Company (2021-2026)
3.2 Global HER2 Target Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global HER2 Target Drugs Revenue by Company (2021-2026)
3.2.2 Global HER2 Target Drugs Revenue Market Share by Company (2021-2026)
3.3 Global HER2 Target Drugs Sale Price by Company
3.4 Key Manufacturers HER2 Target Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HER2 Target Drugs Product Location Distribution
3.4.2 Players HER2 Target Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HER2 TARGET DRUGS BY GEOGRAPHIC REGION
4.1 World Historic HER2 Target Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global HER2 Target Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global HER2 Target Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic HER2 Target Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global HER2 Target Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global HER2 Target Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas HER2 Target Drugs Sales Growth
4.4 APAC HER2 Target Drugs Sales Growth
4.5 Europe HER2 Target Drugs Sales Growth
4.6 Middle East & Africa HER2 Target Drugs Sales Growth
5 AMERICAS
5.1 Americas HER2 Target Drugs Sales by Country
5.1.1 Americas HER2 Target Drugs Sales by Country (2021-2026)
5.1.2 Americas HER2 Target Drugs Revenue by Country (2021-2026)
5.2 Americas HER2 Target Drugs Sales by Type (2021-2026)
5.3 Americas HER2 Target Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Target Drugs Sales by Region
6.1.1 APAC HER2 Target Drugs Sales by Region (2021-2026)
6.1.2 APAC HER2 Target Drugs Revenue by Region (2021-2026)
6.2 APAC HER2 Target Drugs Sales by Type (2021-2026)
6.3 APAC HER2 Target Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HER2 Target Drugs by Country
7.1.1 Europe HER2 Target Drugs Sales by Country (2021-2026)
7.1.2 Europe HER2 Target Drugs Revenue by Country (2021-2026)
7.2 Europe HER2 Target Drugs Sales by Type (2021-2026)
7.3 Europe HER2 Target Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HER2 Target Drugs by Country
8.1.1 Middle East & Africa HER2 Target Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa HER2 Target Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa HER2 Target Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa HER2 Target Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HER2 Target Drugs
10.3 Manufacturing Process Analysis of HER2 Target Drugs
10.4 Industry Chain Structure of HER2 Target Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HER2 Target Drugs Distributors
11.3 HER2 Target Drugs Customer
12 WORLD FORECAST REVIEW FOR HER2 TARGET DRUGS BY GEOGRAPHIC REGION
12.1 Global HER2 Target Drugs Market Size Forecast by Region
12.1.1 Global HER2 Target Drugs Forecast by Region (2027-2032)
12.1.2 Global HER2 Target Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global HER2 Target Drugs Forecast by Type (2027-2032)
12.7 Global HER2 Target Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche HER2 Target Drugs Product Portfolios and Specifications
13.1.3 Roche HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK HER2 Target Drugs Product Portfolios and Specifications
13.2.3 GSK HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Boehringer Digelheim
13.3.1 Boehringer Digelheim Company Information
13.3.2 Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
13.3.3 Boehringer Digelheim HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Digelheim Main Business Overview
13.3.5 Boehringer Digelheim Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer HER2 Target Drugs Product Portfolios and Specifications
13.4.3 Pfizer HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
13.5.3 AstraZeneca HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Seagen
13.6.1 Seagen Company Information
13.6.2 Seagen HER2 Target Drugs Product Portfolios and Specifications
13.6.3 Seagen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Seagen Main Business Overview
13.6.5 Seagen Latest Developments
13.7 MacroGenics
13.7.1 MacroGenics Company Information
13.7.2 MacroGenics HER2 Target Drugs Product Portfolios and Specifications
13.7.3 MacroGenics HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 MacroGenics Main Business Overview
13.7.5 MacroGenics Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda HER2 Target Drugs Product Portfolios and Specifications
13.8.3 Takeda HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Information
13.9.2 Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
13.9.3 Daiichi Sankyo HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Daiichi Sankyo Main Business Overview
13.9.5 Daiichi Sankyo Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG HER2 Target Drugs Product Portfolios and Specifications
13.10.3 Novartis AG HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 RemeGen
13.11.1 RemeGen Company Information
13.11.2 RemeGen HER2 Target Drugs Product Portfolios and Specifications
13.11.3 RemeGen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 RemeGen Main Business Overview
13.11.5 RemeGen Latest Developments
13.12 Sunshine Guojian
13.12.1 Sunshine Guojian Company Information
13.12.2 Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
13.12.3 Sunshine Guojian HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sunshine Guojian Main Business Overview
13.12.5 Sunshine Guojian Latest Developments
13.13 Hengrui Medicine
13.13.1 Hengrui Medicine Company Information
13.13.2 Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
13.13.3 Hengrui Medicine HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hengrui Medicine Main Business Overview
13.13.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HER2 Target Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for HER2 Target Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for HER2 Target Drugs by Country/Region, 2021, 2025 & 2032
2.2 HER2 Target Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecule Chemicals
2.2.3 Antibody Drug Conjugate
2.2.4 HER2 Target Drugs Sales by Type
2.2.4.1 Global HER2 Target Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global HER2 Target Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global HER2 Target Drugs Sale Price by Type (2021-2026)
2.3 HER2 Target Drugs Segment by Application
2.3.1 Breast Cancer
2.3.2 Colorectal Cancer
2.3.3 Stomach Cancer
2.3.4 Other
2.3.5 HER2 Target Drugs Sales by Application
2.3.5.1 Global HER2 Target Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global HER2 Target Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global HER2 Target Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global HER2 Target Drugs Breakdown Data by Company
3.1.1 Global HER2 Target Drugs Annual Sales by Company (2021-2026)
3.1.2 Global HER2 Target Drugs Sales Market Share by Company (2021-2026)
3.2 Global HER2 Target Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global HER2 Target Drugs Revenue by Company (2021-2026)
3.2.2 Global HER2 Target Drugs Revenue Market Share by Company (2021-2026)
3.3 Global HER2 Target Drugs Sale Price by Company
3.4 Key Manufacturers HER2 Target Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HER2 Target Drugs Product Location Distribution
3.4.2 Players HER2 Target Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HER2 TARGET DRUGS BY GEOGRAPHIC REGION
4.1 World Historic HER2 Target Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global HER2 Target Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global HER2 Target Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic HER2 Target Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global HER2 Target Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global HER2 Target Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas HER2 Target Drugs Sales Growth
4.4 APAC HER2 Target Drugs Sales Growth
4.5 Europe HER2 Target Drugs Sales Growth
4.6 Middle East & Africa HER2 Target Drugs Sales Growth
5 AMERICAS
5.1 Americas HER2 Target Drugs Sales by Country
5.1.1 Americas HER2 Target Drugs Sales by Country (2021-2026)
5.1.2 Americas HER2 Target Drugs Revenue by Country (2021-2026)
5.2 Americas HER2 Target Drugs Sales by Type (2021-2026)
5.3 Americas HER2 Target Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Target Drugs Sales by Region
6.1.1 APAC HER2 Target Drugs Sales by Region (2021-2026)
6.1.2 APAC HER2 Target Drugs Revenue by Region (2021-2026)
6.2 APAC HER2 Target Drugs Sales by Type (2021-2026)
6.3 APAC HER2 Target Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HER2 Target Drugs by Country
7.1.1 Europe HER2 Target Drugs Sales by Country (2021-2026)
7.1.2 Europe HER2 Target Drugs Revenue by Country (2021-2026)
7.2 Europe HER2 Target Drugs Sales by Type (2021-2026)
7.3 Europe HER2 Target Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HER2 Target Drugs by Country
8.1.1 Middle East & Africa HER2 Target Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa HER2 Target Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa HER2 Target Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa HER2 Target Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HER2 Target Drugs
10.3 Manufacturing Process Analysis of HER2 Target Drugs
10.4 Industry Chain Structure of HER2 Target Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HER2 Target Drugs Distributors
11.3 HER2 Target Drugs Customer
12 WORLD FORECAST REVIEW FOR HER2 TARGET DRUGS BY GEOGRAPHIC REGION
12.1 Global HER2 Target Drugs Market Size Forecast by Region
12.1.1 Global HER2 Target Drugs Forecast by Region (2027-2032)
12.1.2 Global HER2 Target Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global HER2 Target Drugs Forecast by Type (2027-2032)
12.7 Global HER2 Target Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche HER2 Target Drugs Product Portfolios and Specifications
13.1.3 Roche HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK HER2 Target Drugs Product Portfolios and Specifications
13.2.3 GSK HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Boehringer Digelheim
13.3.1 Boehringer Digelheim Company Information
13.3.2 Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
13.3.3 Boehringer Digelheim HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Digelheim Main Business Overview
13.3.5 Boehringer Digelheim Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer HER2 Target Drugs Product Portfolios and Specifications
13.4.3 Pfizer HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
13.5.3 AstraZeneca HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Seagen
13.6.1 Seagen Company Information
13.6.2 Seagen HER2 Target Drugs Product Portfolios and Specifications
13.6.3 Seagen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Seagen Main Business Overview
13.6.5 Seagen Latest Developments
13.7 MacroGenics
13.7.1 MacroGenics Company Information
13.7.2 MacroGenics HER2 Target Drugs Product Portfolios and Specifications
13.7.3 MacroGenics HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 MacroGenics Main Business Overview
13.7.5 MacroGenics Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda HER2 Target Drugs Product Portfolios and Specifications
13.8.3 Takeda HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Information
13.9.2 Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
13.9.3 Daiichi Sankyo HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Daiichi Sankyo Main Business Overview
13.9.5 Daiichi Sankyo Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG HER2 Target Drugs Product Portfolios and Specifications
13.10.3 Novartis AG HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 RemeGen
13.11.1 RemeGen Company Information
13.11.2 RemeGen HER2 Target Drugs Product Portfolios and Specifications
13.11.3 RemeGen HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 RemeGen Main Business Overview
13.11.5 RemeGen Latest Developments
13.12 Sunshine Guojian
13.12.1 Sunshine Guojian Company Information
13.12.2 Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
13.12.3 Sunshine Guojian HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sunshine Guojian Main Business Overview
13.12.5 Sunshine Guojian Latest Developments
13.13 Hengrui Medicine
13.13.1 Hengrui Medicine Company Information
13.13.2 Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
13.13.3 Hengrui Medicine HER2 Target Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hengrui Medicine Main Business Overview
13.13.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. HER2 Target Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. HER2 Target Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small Molecule Chemicals
Table 5. Major Players of Antibody Drug Conjugate
Table 6. Global HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global HER2 Target Drugs Sales Market Share by Type (2021-2026)
Table 8. Global HER2 Target Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global HER2 Target Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global HER2 Target Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global HER2 Target Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global HER2 Target Drugs Sale Market Share by Application (2021-2026)
Table 13. Global HER2 Target Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global HER2 Target Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global HER2 Target Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global HER2 Target Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global HER2 Target Drugs Sales Market Share by Company (2021-2026)
Table 18. Global HER2 Target Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global HER2 Target Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global HER2 Target Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers HER2 Target Drugs Producing Area Distribution and Sales Area
Table 22. Players HER2 Target Drugs Products Offered
Table 23. HER2 Target Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global HER2 Target Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global HER2 Target Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global HER2 Target Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global HER2 Target Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global HER2 Target Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global HER2 Target Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global HER2 Target Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global HER2 Target Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas HER2 Target Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas HER2 Target Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas HER2 Target Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas HER2 Target Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC HER2 Target Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC HER2 Target Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC HER2 Target Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC HER2 Target Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe HER2 Target Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe HER2 Target Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe HER2 Target Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa HER2 Target Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa HER2 Target Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa HER2 Target Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of HER2 Target Drugs
Table 53. Key Market Challenges & Risks of HER2 Target Drugs
Table 54. Key Industry Trends of HER2 Target Drugs
Table 55. HER2 Target Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. HER2 Target Drugs Distributors List
Table 58. HER2 Target Drugs Customer List
Table 59. Global HER2 Target Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global HER2 Target Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas HER2 Target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas HER2 Target Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC HER2 Target Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC HER2 Target Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe HER2 Target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe HER2 Target Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa HER2 Target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa HER2 Target Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global HER2 Target Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global HER2 Target Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global HER2 Target Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global HER2 Target Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Roche Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Roche HER2 Target Drugs Product Portfolios and Specifications
Table 75. Roche HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Roche Main Business
Table 77. Roche Latest Developments
Table 78. GSK Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK HER2 Target Drugs Product Portfolios and Specifications
Table 80. GSK HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Boehringer Digelheim Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
Table 85. Boehringer Digelheim HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Boehringer Digelheim Main Business
Table 87. Boehringer Digelheim Latest Developments
Table 88. Pfizer Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer HER2 Target Drugs Product Portfolios and Specifications
Table 90. Pfizer HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. AstraZeneca Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
Table 95. AstraZeneca HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. AstraZeneca Main Business
Table 97. AstraZeneca Latest Developments
Table 98. Seagen Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Seagen HER2 Target Drugs Product Portfolios and Specifications
Table 100. Seagen HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Seagen Main Business
Table 102. Seagen Latest Developments
Table 103. MacroGenics Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. MacroGenics HER2 Target Drugs Product Portfolios and Specifications
Table 105. MacroGenics HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. MacroGenics Main Business
Table 107. MacroGenics Latest Developments
Table 108. Takeda Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Takeda HER2 Target Drugs Product Portfolios and Specifications
Table 110. Takeda HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Takeda Main Business
Table 112. Takeda Latest Developments
Table 113. Daiichi Sankyo Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
Table 115. Daiichi Sankyo HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Daiichi Sankyo Main Business
Table 117. Daiichi Sankyo Latest Developments
Table 118. Novartis AG Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AG HER2 Target Drugs Product Portfolios and Specifications
Table 120. Novartis AG HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
Table 123. RemeGen Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. RemeGen HER2 Target Drugs Product Portfolios and Specifications
Table 125. RemeGen HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. RemeGen Main Business
Table 127. RemeGen Latest Developments
Table 128. Sunshine Guojian Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
Table 130. Sunshine Guojian HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Sunshine Guojian Main Business
Table 132. Sunshine Guojian Latest Developments
Table 133. Hengrui Medicine Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
Table 135. Hengrui Medicine HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Hengrui Medicine Main Business
Table 137. Hengrui Medicine Latest Developments
Table 1. HER2 Target Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. HER2 Target Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small Molecule Chemicals
Table 5. Major Players of Antibody Drug Conjugate
Table 6. Global HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global HER2 Target Drugs Sales Market Share by Type (2021-2026)
Table 8. Global HER2 Target Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global HER2 Target Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global HER2 Target Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global HER2 Target Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global HER2 Target Drugs Sale Market Share by Application (2021-2026)
Table 13. Global HER2 Target Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global HER2 Target Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global HER2 Target Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global HER2 Target Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global HER2 Target Drugs Sales Market Share by Company (2021-2026)
Table 18. Global HER2 Target Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global HER2 Target Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global HER2 Target Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers HER2 Target Drugs Producing Area Distribution and Sales Area
Table 22. Players HER2 Target Drugs Products Offered
Table 23. HER2 Target Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global HER2 Target Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global HER2 Target Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global HER2 Target Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global HER2 Target Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global HER2 Target Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global HER2 Target Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global HER2 Target Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global HER2 Target Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas HER2 Target Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas HER2 Target Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas HER2 Target Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas HER2 Target Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC HER2 Target Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC HER2 Target Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC HER2 Target Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC HER2 Target Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe HER2 Target Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe HER2 Target Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe HER2 Target Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa HER2 Target Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa HER2 Target Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa HER2 Target Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa HER2 Target Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of HER2 Target Drugs
Table 53. Key Market Challenges & Risks of HER2 Target Drugs
Table 54. Key Industry Trends of HER2 Target Drugs
Table 55. HER2 Target Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. HER2 Target Drugs Distributors List
Table 58. HER2 Target Drugs Customer List
Table 59. Global HER2 Target Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global HER2 Target Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas HER2 Target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas HER2 Target Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC HER2 Target Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC HER2 Target Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe HER2 Target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe HER2 Target Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa HER2 Target Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa HER2 Target Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global HER2 Target Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global HER2 Target Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global HER2 Target Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global HER2 Target Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Roche Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Roche HER2 Target Drugs Product Portfolios and Specifications
Table 75. Roche HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Roche Main Business
Table 77. Roche Latest Developments
Table 78. GSK Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK HER2 Target Drugs Product Portfolios and Specifications
Table 80. GSK HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Boehringer Digelheim Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Digelheim HER2 Target Drugs Product Portfolios and Specifications
Table 85. Boehringer Digelheim HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Boehringer Digelheim Main Business
Table 87. Boehringer Digelheim Latest Developments
Table 88. Pfizer Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer HER2 Target Drugs Product Portfolios and Specifications
Table 90. Pfizer HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. AstraZeneca Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. AstraZeneca HER2 Target Drugs Product Portfolios and Specifications
Table 95. AstraZeneca HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. AstraZeneca Main Business
Table 97. AstraZeneca Latest Developments
Table 98. Seagen Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Seagen HER2 Target Drugs Product Portfolios and Specifications
Table 100. Seagen HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Seagen Main Business
Table 102. Seagen Latest Developments
Table 103. MacroGenics Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. MacroGenics HER2 Target Drugs Product Portfolios and Specifications
Table 105. MacroGenics HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. MacroGenics Main Business
Table 107. MacroGenics Latest Developments
Table 108. Takeda Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Takeda HER2 Target Drugs Product Portfolios and Specifications
Table 110. Takeda HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Takeda Main Business
Table 112. Takeda Latest Developments
Table 113. Daiichi Sankyo Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Daiichi Sankyo HER2 Target Drugs Product Portfolios and Specifications
Table 115. Daiichi Sankyo HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Daiichi Sankyo Main Business
Table 117. Daiichi Sankyo Latest Developments
Table 118. Novartis AG Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AG HER2 Target Drugs Product Portfolios and Specifications
Table 120. Novartis AG HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
Table 123. RemeGen Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. RemeGen HER2 Target Drugs Product Portfolios and Specifications
Table 125. RemeGen HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. RemeGen Main Business
Table 127. RemeGen Latest Developments
Table 128. Sunshine Guojian Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Sunshine Guojian HER2 Target Drugs Product Portfolios and Specifications
Table 130. Sunshine Guojian HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Sunshine Guojian Main Business
Table 132. Sunshine Guojian Latest Developments
Table 133. Hengrui Medicine Basic Information, HER2 Target Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Hengrui Medicine HER2 Target Drugs Product Portfolios and Specifications
Table 135. Hengrui Medicine HER2 Target Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Hengrui Medicine Main Business
Table 137. Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Picture of HER2 Target Drugs
Figure 2. HER2 Target Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HER2 Target Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global HER2 Target Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. HER2 Target Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. HER2 Target Drugs Sales Market Share by Country/Region (2025)
Figure 10. HER2 Target Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Small Molecule Chemicals
Figure 13. Product Picture of Antibody Drug Conjugate
Figure 14. Global HER2 Target Drugs Sales Market Share by Type in 2026
Figure 15. Global HER2 Target Drugs Revenue Market Share by Type (2021-2026)
Figure 16. HER2 Target Drugs Consumed in Breast Cancer
Figure 17. Global HER2 Target Drugs Market: Breast Cancer (2021-2026) & (K Units)
Figure 18. HER2 Target Drugs Consumed in Colorectal Cancer
Figure 19. Global HER2 Target Drugs Market: Colorectal Cancer (2021-2026) & (K Units)
Figure 20. HER2 Target Drugs Consumed in Stomach Cancer
Figure 21. Global HER2 Target Drugs Market: Stomach Cancer (2021-2026) & (K Units)
Figure 22. HER2 Target Drugs Consumed in Other
Figure 23. Global HER2 Target Drugs Market: Other (2021-2026) & (K Units)
Figure 24. Global HER2 Target Drugs Sale Market Share by Application (2025)
Figure 25. Global HER2 Target Drugs Revenue Market Share by Application in 2026
Figure 26. HER2 Target Drugs Sales by Company in 2026 (K Units)
Figure 27. Global HER2 Target Drugs Sales Market Share by Company in 2026
Figure 28. HER2 Target Drugs Revenue by Company in 2026 ($ millions)
Figure 29. Global HER2 Target Drugs Revenue Market Share by Company in 2026
Figure 30. Global HER2 Target Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global HER2 Target Drugs Revenue Market Share by Geographic Region in 2026
Figure 32. Americas HER2 Target Drugs Sales 2021-2026 (K Units)
Figure 33. Americas HER2 Target Drugs Revenue 2021-2026 ($ millions)
Figure 34. APAC HER2 Target Drugs Sales 2021-2026 (K Units)
Figure 35. APAC HER2 Target Drugs Revenue 2021-2026 ($ millions)
Figure 36. Europe HER2 Target Drugs Sales 2021-2026 (K Units)
Figure 37. Europe HER2 Target Drugs Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa HER2 Target Drugs Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa HER2 Target Drugs Revenue 2021-2026 ($ millions)
Figure 40. Americas HER2 Target Drugs Sales Market Share by Country in 2026
Figure 41. Americas HER2 Target Drugs Revenue Market Share by Country (2021-2026)
Figure 42. Americas HER2 Target Drugs Sales Market Share by Type (2021-2026)
Figure 43. Americas HER2 Target Drugs Sales Market Share by Application (2021-2026)
Figure 44. United States HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC HER2 Target Drugs Sales Market Share by Region in 2026
Figure 49. APAC HER2 Target Drugs Revenue Market Share by Region (2021-2026)
Figure 50. APAC HER2 Target Drugs Sales Market Share by Type (2021-2026)
Figure 51. APAC HER2 Target Drugs Sales Market Share by Application (2021-2026)
Figure 52. China HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. India HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe HER2 Target Drugs Sales Market Share by Country in 2026
Figure 60. Europe HER2 Target Drugs Revenue Market Share by Country (2021-2026)
Figure 61. Europe HER2 Target Drugs Sales Market Share by Type (2021-2026)
Figure 62. Europe HER2 Target Drugs Sales Market Share by Application (2021-2026)
Figure 63. Germany HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. France HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. UK HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa HER2 Target Drugs Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa HER2 Target Drugs Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa HER2 Target Drugs Sales Market Share by Application (2021-2026)
Figure 71. Egypt HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of HER2 Target Drugs in 2026
Figure 77. Manufacturing Process Analysis of HER2 Target Drugs
Figure 78. Industry Chain Structure of HER2 Target Drugs
Figure 79. Channels of Distribution
Figure 80. Global HER2 Target Drugs Sales Market Forecast by Region (2027-2032)
Figure 81. Global HER2 Target Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global HER2 Target Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global HER2 Target Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global HER2 Target Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global HER2 Target Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of HER2 Target Drugs
Figure 2. HER2 Target Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HER2 Target Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global HER2 Target Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. HER2 Target Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. HER2 Target Drugs Sales Market Share by Country/Region (2025)
Figure 10. HER2 Target Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Small Molecule Chemicals
Figure 13. Product Picture of Antibody Drug Conjugate
Figure 14. Global HER2 Target Drugs Sales Market Share by Type in 2026
Figure 15. Global HER2 Target Drugs Revenue Market Share by Type (2021-2026)
Figure 16. HER2 Target Drugs Consumed in Breast Cancer
Figure 17. Global HER2 Target Drugs Market: Breast Cancer (2021-2026) & (K Units)
Figure 18. HER2 Target Drugs Consumed in Colorectal Cancer
Figure 19. Global HER2 Target Drugs Market: Colorectal Cancer (2021-2026) & (K Units)
Figure 20. HER2 Target Drugs Consumed in Stomach Cancer
Figure 21. Global HER2 Target Drugs Market: Stomach Cancer (2021-2026) & (K Units)
Figure 22. HER2 Target Drugs Consumed in Other
Figure 23. Global HER2 Target Drugs Market: Other (2021-2026) & (K Units)
Figure 24. Global HER2 Target Drugs Sale Market Share by Application (2025)
Figure 25. Global HER2 Target Drugs Revenue Market Share by Application in 2026
Figure 26. HER2 Target Drugs Sales by Company in 2026 (K Units)
Figure 27. Global HER2 Target Drugs Sales Market Share by Company in 2026
Figure 28. HER2 Target Drugs Revenue by Company in 2026 ($ millions)
Figure 29. Global HER2 Target Drugs Revenue Market Share by Company in 2026
Figure 30. Global HER2 Target Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global HER2 Target Drugs Revenue Market Share by Geographic Region in 2026
Figure 32. Americas HER2 Target Drugs Sales 2021-2026 (K Units)
Figure 33. Americas HER2 Target Drugs Revenue 2021-2026 ($ millions)
Figure 34. APAC HER2 Target Drugs Sales 2021-2026 (K Units)
Figure 35. APAC HER2 Target Drugs Revenue 2021-2026 ($ millions)
Figure 36. Europe HER2 Target Drugs Sales 2021-2026 (K Units)
Figure 37. Europe HER2 Target Drugs Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa HER2 Target Drugs Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa HER2 Target Drugs Revenue 2021-2026 ($ millions)
Figure 40. Americas HER2 Target Drugs Sales Market Share by Country in 2026
Figure 41. Americas HER2 Target Drugs Revenue Market Share by Country (2021-2026)
Figure 42. Americas HER2 Target Drugs Sales Market Share by Type (2021-2026)
Figure 43. Americas HER2 Target Drugs Sales Market Share by Application (2021-2026)
Figure 44. United States HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC HER2 Target Drugs Sales Market Share by Region in 2026
Figure 49. APAC HER2 Target Drugs Revenue Market Share by Region (2021-2026)
Figure 50. APAC HER2 Target Drugs Sales Market Share by Type (2021-2026)
Figure 51. APAC HER2 Target Drugs Sales Market Share by Application (2021-2026)
Figure 52. China HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. India HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe HER2 Target Drugs Sales Market Share by Country in 2026
Figure 60. Europe HER2 Target Drugs Revenue Market Share by Country (2021-2026)
Figure 61. Europe HER2 Target Drugs Sales Market Share by Type (2021-2026)
Figure 62. Europe HER2 Target Drugs Sales Market Share by Application (2021-2026)
Figure 63. Germany HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. France HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. UK HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa HER2 Target Drugs Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa HER2 Target Drugs Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa HER2 Target Drugs Sales Market Share by Application (2021-2026)
Figure 71. Egypt HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries HER2 Target Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of HER2 Target Drugs in 2026
Figure 77. Manufacturing Process Analysis of HER2 Target Drugs
Figure 78. Industry Chain Structure of HER2 Target Drugs
Figure 79. Channels of Distribution
Figure 80. Global HER2 Target Drugs Sales Market Forecast by Region (2027-2032)
Figure 81. Global HER2 Target Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global HER2 Target Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global HER2 Target Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global HER2 Target Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global HER2 Target Drugs Revenue Market Share Forecast by Application (2027-2032)
